These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26690889)

  • 1. One year in review 2015: spondyloarthritis.
    Giovannini L; Orlandi M; Lodato C; Cioffi E; Tenti S; Bardelli M; Talarico R; Guiducci S
    Clin Exp Rheumatol; 2015; 33(6):769-78. PubMed ID: 26690889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One year in review 2016: spondyloarthritis.
    Parma A; Cometi L; Leone MC; Lepri G; Talarico R; Guiducci S
    Clin Exp Rheumatol; 2017; 35(1):3-17. PubMed ID: 28150582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spondyloarthritis: from unifying concepts to improved treatment.
    Paramarta JE; Baeten D
    Rheumatology (Oxford); 2014 Sep; 53(9):1547-59. PubMed ID: 24369419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psoriatic arthritis and general recommendations for targeted therapy of spondyloarthritis].
    Märker-Hermann E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):2037-40. PubMed ID: 24065412
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology and role of the gastrointestinal system in spondyloarthritides.
    Jacques P; Van Praet L; Carron P; Van den Bosch F; Elewaut D
    Rheum Dis Clin North Am; 2012 Aug; 38(3):569-82. PubMed ID: 23083756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.
    Smith JA
    Curr Rheumatol Rep; 2016 Jun; 18(6):33. PubMed ID: 27105640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological drug treatment of rheumatoid arthritis and spondyloarthritis: effects on QT interval and QT dispersion.
    DI Franco M; Paradiso M; Ceccarelli F; Scrivo R; Spinelli FR; Iannuccelli C; Valesini G
    J Rheumatol; 2012 Jan; 39(1):41-5. PubMed ID: 22045840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do non-steroidal anti-inflammatory drugs have disease-modifying effects in spondyloarthritis?
    Wendling D
    Joint Bone Spine; 2013 Dec; 80(6):563-4. PubMed ID: 23831397
    [No Abstract]   [Full Text] [Related]  

  • 9. Early spondyloarthritis.
    Poddubnyy D; Rudwaleit M
    Rheum Dis Clin North Am; 2012 May; 38(2):387-403. PubMed ID: 22819091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments with experimental and investigational drugs for axial spondyloarthritis.
    Clavel G; Boissier MC; Sigaux J; Semerano L
    Expert Opin Investig Drugs; 2017 Jul; 26(7):833-842. PubMed ID: 28562100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TNF-α inhibitors on abdominal adiposity in patients with inflammatory rheumatic diseases.
    Toussirot É; Dumoulin G
    J Rheumatol; 2014 Dec; 41(12):2491. PubMed ID: 25452185
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis.
    Villiger PM; Caliezi G; Cottin V; Förger F; Senn A; Østensen M
    Ann Rheum Dis; 2010 Oct; 69(10):1842-4. PubMed ID: 20610443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for spondyloarthritis: the role of extra-articular manifestations (eye, skin).
    Carron P; Van Praet L; Jacques P; Elewaut D; Van den Bosch F
    Rheum Dis Clin North Am; 2012 Aug; 38(3):583-600. PubMed ID: 23083757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular involvement in spondylarthritis--new mechanisms, new therapies].
    Itulescu TC; Alexandrescu C; Voinea LM
    Oftalmologia; 2014; 58(1):27-35. PubMed ID: 25145120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dr. Hmamouchi, et al reply.
    Hmamouchi I; Roux C; Paternotte S; Kolta S; Dougados M; Briot K
    J Rheumatol; 2014 Dec; 41(12):2492. PubMed ID: 25452186
    [No Abstract]   [Full Text] [Related]  

  • 16. Spondyloarthritis in 2012: Advances in pathogenesis through animal models and imaging.
    Maksymowych WP
    Nat Rev Rheumatol; 2013 Feb; 9(2):72-4. PubMed ID: 23296391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.
    Hmamouchi I; Roux C; Paternotte S; Kolta S; Dougados M; Briot K
    J Rheumatol; 2014 Jun; 41(6):1112-7. PubMed ID: 24737911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease.
    Paccou J; Nachury M; Duchemin C; Desreumaux P; Flipo RM; Pariente B
    Joint Bone Spine; 2019 Oct; 86(5):654-656. PubMed ID: 30711690
    [No Abstract]   [Full Text] [Related]  

  • 19. Insights into uveitis in association with spondyloarthritis from a large patient survey.
    Keck KM; Choi D; Savage LM; Rosenbaum JT
    J Clin Rheumatol; 2014 Apr; 20(3):141-5. PubMed ID: 24662555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study.
    Durnez A; Paternotte S; Fechtenbaum J; Landewé RB; Dougados M; Roux C; Briot K
    J Rheumatol; 2013 Oct; 40(10):1712-8. PubMed ID: 23950191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.